Omeprazol Sandoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders in adults, such as gastro‑esophageal reflux disease and peptic ulcer disease.

GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution, ensuring timely delivery and regulatory support for all authorized buyers.

Omeprazol Sandoz, a proton pump inhibitor, is indicated for several acid‑related gastrointestinal conditions.

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing stomach acid. - Erosive esophagitis: promotes healing of damaged esophageal lining. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication (in combination therapy): enhances bacterial clearance. - Zollinger‑Ellison syndrome: controls excessive gastric acid production.

Common Side Effects: - Headache: mild to moderate pain often transient. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of unease or urge to vomit. - Diarrhea: loose, watery stools. - Flatulence: excess gas in the gastrointestinal tract. - Constipation: infrequent or hard stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Elevated liver enzymes: signs of hepatic stress. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Increased risk of bone fractures with long‑term use.

Omeprazol Sandoz should be used with clinical oversight and consideration of patient‑specific factors. - Renal or hepatic impairment: assess function before initiating therapy. - Elderly patients: monitor for electrolyte disturbances and drug interactions. - Long‑term use: evaluate necessity periodically to avoid potential risks. - Magnesium monitoring: consider supplementation if therapy exceeds several months. - Concomitant medications: review for possible interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazol Sandoz may alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clarithromycin: increased omeprazole exposure may raise risk of adverse effects. - Ketoconazole: reduced absorption due to higher gastric pH. - Atazanavir: diminished antiviral efficacy. - HIV protease inhibitors (e.g., ritonavir): decreased plasma levels. - Clopidogrel: reduced antiplatelet activation.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum concentration. - Methotrexate: reduced clearance may lead to toxicity. - Phenytoin: altered metabolism affecting seizure control. - Phenobarbital: decreased omeprazole effectiveness. - Warfarin: potential enhancement of anticoagulant effect.